Chambers Global Practice Guide: Life Sciences & Pharma IP Litigation 2024 - Singapore chapter by Drew & Napier

14 Mar 2024

Managing Director of Intellectual Property Tony Yeo, Directors Meryl Koh and Rozalynne Asmali and Associate Director Javier Yeo co-authored the Singapore chapter in the Chambers Global Practice Guide: Life Sciences & Pharma IP Litigation 2024.

The Life Sciences & Pharma IP Litigation 2024 guide has expanded to 18 jurisdictions. The guide covers the latest developments in patent litigation, generic and biosimilar market entry, patent term extensions, available forms of relief, other IP rights, appeal, ADR and settlement/antitrust considerations.

You may read the full chapter here.

Reproduced with permission from Chambers Global Practice Guides. This article was published in February 2024; contributing editor: Nicola Dagg from Kirkland & Ellis International LLP. For further information, please visit Chambers and Partners' website.